Technical Analysis for VPHIF - Valeo Pharma Inc

Grade Last Price % Change Price Change
A 0.9599 5.03% 0.0460
VPHIF closed up 5.03 percent on Wednesday, May 12, 2021, on 30 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical VPHIF trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 5.03%
MACD Bearish Signal Line Cross Bearish 5.03%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.03%
Narrow Range Bar Range Contraction 5.03%
Down 3 Days in a Row Weakness 5.03%
Down 4 Days in a Row Weakness 5.03%
Older End-of-Day Signals for VPHIF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Valeo Pharma Inc Description

Valeo Pharma Inc. acquires and markets specialty products in the United States and Canada. Its product portfolio includes Synacthen, a neurology therapeutic for the treatment of severe multiple sclerosis and gout; and M-Eslon, an extended release morphine sulphate used for pain management. The company also offers Ondansetron ODT for prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Onstryv, a safinamide tablet used to treat idiopathic Parkinson's disease. In addition, it develops Ethacrynate Sodium, a loop diuretic used to treat high blood pressure, as well as the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure. The company was founded in 2003 and is headquartered in Kirkland, Canada.


Classification

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Keywords: Cancer Drugs Psychoactive Drugs Pain Diseases Chemotherapy Parkinson's Disease Pain Management Antiemetics Treatment Of Parkinson's Disease Nausea Gout High Blood Pressure Vomiting Kidney Failure Tardive Dyskinesia Liver Failure Muscarinic Antagonists Safinamide

Is VPHIF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.4
52 Week Low 0.5949
Average Volume 13,246
200-Day Moving Average 0.0000
50-Day Moving Average 0.8896
20-Day Moving Average 0.9259
10-Day Moving Average 0.9464
Average True Range 0.0655
ADX 12.42
+DI 32.0109
-DI 40.5450
Chandelier Exit (Long, 3 ATRs ) 0.9035
Chandelier Exit (Short, 3 ATRs ) 0.8223
Upper Bollinger Band 1.0201
Lower Bollinger Band 0.8317
Percent B (%b) 0.68
BandWidth 20.3478
MACD Line 0.0170
MACD Signal Line 0.0172
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.9950
Resistance 3 (R3) 0.9916 0.9765 0.9892
Resistance 2 (R2) 0.9765 0.9676 0.9782 0.9872
Resistance 1 (R1) 0.9682 0.9620 0.9724 0.9716 0.9852
Pivot Point 0.9531 0.9531 0.9552 0.9548 0.9531
Support 1 (S1) 0.9448 0.9442 0.9490 0.9482 0.9346
Support 2 (S2) 0.9297 0.9386 0.9314 0.9326
Support 3 (S3) 0.9214 0.9297 0.9307
Support 4 (S4) 0.9248